158
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin

, , , , , , & show all
Pages 415-425 | Received 29 Apr 2014, Accepted 20 Jun 2014, Published online: 25 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maliheh Ghadiri, Paul M Young & Daniela Traini. (2016) Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease. Expert Opinion on Biological Therapy 16:3, pages 375-387.
Read now

Articles from other publishers (2)

Colin E. Evans, Yi Peng, Maggie M. Zhu, Zhiyu Dai, Xianming Zhang & You-Yang Zhao. (2022) Rabeprazole Promotes Vascular Repair and Resolution of Sepsis-Induced Inflammatory Lung Injury through HIF-1α. Cells 11:9, pages 1425.
Crossref
Robert M. Tighe, Elizabeth F. Redente, Yen-Rei Yu, Susanne Herold, Anne I. Sperling, Jeffrey L. Curtis, Ryan Duggan, Suchitra Swaminathan, Hideki Nakano, William J. Zacharias, William J. Janssen, Christine M. Freeman, Ryan R. Brinkman, Benjamin D. Singer, Claudia V. Jakubzick & Alexander V. Misharin. (2019) Improving the Quality and Reproducibility of Flow Cytometry in the Lung. An Official American Thoracic Society Workshop Report. American Journal of Respiratory Cell and Molecular Biology 61:2, pages 150-161.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.